riluzole has been researched along with Cell Transformation, Neoplastic in 2 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teh, JL | 1 |
| Shah, R | 1 |
| La Cava, S | 1 |
| Dolfi, SC | 1 |
| Mehta, MS | 1 |
| Kongara, S | 1 |
| Price, S | 1 |
| Ganesan, S | 1 |
| Reuhl, KR | 1 |
| Hirshfield, KM | 1 |
| Karantza, V | 1 |
| Chen, S | 2 |
| Martino, JJ | 1 |
| Wall, BA | 1 |
| Mastrantoni, E | 1 |
| Wilimczyk, BJ | 1 |
| La Cava, SN | 1 |
| Degenhardt, K | 1 |
| White, E | 1 |
2 other studies available for riluzole and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Transformation, Neoplastic; Female; G | 2015 |
Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplasti | 2013 |